Literature DB >> 10889802

Dietary treatment of thrombogenic disorders related to the metabolic syndrome.

P Marckmann1.   

Abstract

The increased risk of coronary heart disease associated with the metabolic syndrome may be partially explained by prothrombotic deviations of the haemostatic system. Individuals with insulin resistance, dyslipidaemia and obesity are characterized by elevated plasma fibrinogen and factor VII coagulant activity levels and raised concentrations of plasminogen-activator inhibitor, the main inhibitor of endogenous fibrinolysis. These haemostatic abnormalities may be corrected with dietary treatment of the underlying clinical disorder. Dietary trials of diseased and healthy volunteers suggest that the optimal antithrombotic diet is a low-fat diet with a high content of foods rich in complex carbohydrates and dietary fibre. The dietary fatty acid composition has a profound effect on blood lipids, but seems of minor importance for the haemostatic system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10889802     DOI: 10.1017/s0007114500001057

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  12 in total

Review 1.  Fructose-containing sugars and cardiovascular disease.

Authors:  James M Rippe; Theodore J Angelopoulos
Journal:  Adv Nutr       Date:  2015-07-15       Impact factor: 8.701

Review 2.  What is the appropriate upper limit for added sugars consumption?

Authors:  James M Rippe; John L Sievenpiper; Kim-Anne Lê; John S White; Roger Clemens; Theodore J Angelopoulos
Journal:  Nutr Rev       Date:  2017-01       Impact factor: 7.110

3.  Cross-sectional association between sugar-sweetened beverage intake and cardiometabolic biomarkers in US women.

Authors:  Zhi Yu; Sylvia H Ley; Qi Sun; Frank B Hu; Vasanti S Malik
Journal:  Br J Nutr       Date:  2018-03       Impact factor: 3.718

Review 4.  Added sugars and risk factors for obesity, diabetes and heart disease.

Authors:  J M Rippe; T J Angelopoulos
Journal:  Int J Obes (Lond)       Date:  2016-03       Impact factor: 5.095

Review 5.  Coagulation and fibrinolysis abnormalities in obesity.

Authors:  G De Pergola; N Pannacciulli
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

6.  Controversies about sugars consumption: state of the science.

Authors:  James M Rippe; Ascensión Marcos
Journal:  Eur J Nutr       Date:  2016-06-20       Impact factor: 5.614

Review 7.  Relationship between Added Sugars Consumption and Chronic Disease Risk Factors: Current Understanding.

Authors:  James M Rippe; Theodore J Angelopoulos
Journal:  Nutrients       Date:  2016-11-04       Impact factor: 5.717

Review 8.  Sucrose, high-fructose corn syrup, and fructose, their metabolism and potential health effects: what do we really know?

Authors:  James M Rippe; Theodore J Angelopoulos
Journal:  Adv Nutr       Date:  2013-03-01       Impact factor: 8.701

Review 9.  The metabolic and endocrine response and health implications of consuming sugar-sweetened beverages: findings from recent randomized controlled trials.

Authors:  James M Rippe
Journal:  Adv Nutr       Date:  2013-11-06       Impact factor: 8.701

10.  Fructose Containing Sugars at Normal Levels of Consumption Do Not Effect Adversely Components of the Metabolic Syndrome and Risk Factors for Cardiovascular Disease.

Authors:  Theodore J Angelopoulos; Joshua Lowndes; Stephanie Sinnett; James M Rippe
Journal:  Nutrients       Date:  2016-03-23       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.